Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Reducing the Dietary Acid Load: How a More Alkaline Diet Benefits Patients With Chronic Kidney Disease.
Passey C. Passey C. J Ren Nutr. 2017 May;27(3):151-160. doi: 10.1053/j.jrn.2016.11.006. Epub 2017 Jan 20. J Ren Nutr. 2017. PMID: 28117137 Review.
Energy balance in predialysis patients on a low-protein diet.
Passey C, Bunker V, Jackson A, Lee H. Passey C, et al. J Ren Nutr. 2003 Apr;13(2):120-5. doi: 10.1053/jren.2003.50014. J Ren Nutr. 2003. PMID: 12671835
The reported use of dietary supplements (sip feeds) in hospitals in Wessex, UK.
Brosnan S, Margetts B, Munro J, Passey C, Rivers H; Wessex Dietetic Managers Group. Brosnan S, et al. Among authors: passey c. Clin Nutr. 2001 Oct;20(5):445-9. doi: 10.1054/clnu.2001.0468. Clin Nutr. 2001. PMID: 11534940
Concurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2 KCNT1 Mutations.
Passey CC, Erramouspe J, Castellanos P, O'Donnell EC, Denton DM. Passey CC, et al. Curr Ther Res Clin Exp. 2019 Feb 28;90:106-108. doi: 10.1016/j.curtheres.2019.02.002. eCollection 2019. Curr Ther Res Clin Exp. 2019. PMID: 31388363 Free PMC article.
Methods for determining key components in a mathematical model for tumor-immune dynamics in multiple myeloma.
Gallaher J, Larripa K, Renardy M, Shtylla B, Tania N, White D, Wood K, Zhu L, Passey C, Robbins M, Bezman N, Shelat S, Jay Cho H, Moore H. Gallaher J, et al. Among authors: passey c. J Theor Biol. 2018 Dec 7;458:31-46. doi: 10.1016/j.jtbi.2018.08.037. Epub 2018 Aug 30. J Theor Biol. 2018. PMID: 30172689
Reporting, Visualization, and Modeling of Immunogenicity Data to Assess Its Impact on Pharmacokinetics, Efficacy, and Safety of Monoclonal Antibodies.
Passey C, Suryawanshi S, Sanghavi K, Gupta M. Passey C, et al. AAPS J. 2018 Feb 26;20(2):35. doi: 10.1208/s12248-018-0194-9. AAPS J. 2018. PMID: 29484520 Review.
The Clinical Pharmacology of Elotuzumab.
Passey C, Sheng J, Mora J, Tendolkar A, Robbins M, Dodge R, Roy A, Bello A, Gupta M. Passey C, et al. Clin Pharmacokinet. 2018 Mar;57(3):297-313. doi: 10.1007/s40262-017-0585-6. Clin Pharmacokinet. 2018. PMID: 28779463 Review.
An Integrated Assessment of the Effects of Immunogenicity on the Pharmacokinetics, Safety, and Efficacy of Elotuzumab.
Passey C, Mora J, Dodge R, Gibiansky L, Sheng J, Roy A, Bello A, Gupta M. Passey C, et al. AAPS J. 2017 Mar;19(2):557-567. doi: 10.1208/s12248-016-0033-9. Epub 2017 Jan 9. AAPS J. 2017. PMID: 28070715
Effects of elotuzumab on QT interval and cardiac safety in patients with multiple myeloma.
Passey C, Darbenzio R, Jou YM, Lynch M, Gupta M. Passey C, et al. Cancer Chemother Pharmacol. 2016 Dec;78(6):1237-1244. doi: 10.1007/s00280-016-3182-8. Epub 2016 Oct 28. Cancer Chemother Pharmacol. 2016. PMID: 27796540
Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myeloma.
Gibiansky L, Passey C, Roy A, Bello A, Gupta M. Gibiansky L, et al. Among authors: passey c. J Pharmacokinet Pharmacodyn. 2016 Jun;43(3):243-57. doi: 10.1007/s10928-016-9469-x. Epub 2016 Mar 18. J Pharmacokinet Pharmacodyn. 2016. PMID: 26993283
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback